Antonetti Capital Management’s AstraZeneca AZN Stock Holding History

Antonetti Capital Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$13.5K	Hold	100	–	–	0.02%	187
2023 Q2	$14.3K	Hold	100	–	–	0.02%	197
2023 Q1	$13.9K	Hold	100	–	–	0.02%	198
2022 Q4	$13.6K	Hold	100	–	–	0.02%	199
2022 Q3	$11K	Hold	100	–	–	0.01%	212
2022 Q2	$13K	Sell	100 -50	-33%	-$6.56K	0.01%	208
2022 Q1	$20K	Hold	150	–	–	0.02%	203
2021 Q4	$17K	Hold	150	–	–	0.01%	254
2021 Q3	$18K	Buy	+150	New	+$17.5K	0.01%	256
2014 Q1	–	Sell	-499	Closed	-$30K	–	237
2013 Q4	$30K	Hold	499	–	–	0.03%	148
2013 Q3	$26K	Hold	499	–	–	0.03%	191
2013 Q2	$24K	Buy	+499	New	+$25.4K	0.03%	204

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Antonetti Capital Management's AZN Position: Q3 2023 in Review

Antonetti Capital Management held its AstraZeneca (AZN) position steady in Q3 2023 at 100 shares worth $13.5K. The position accounts for 0.02% of the portfolio, ranked #187.

Antonetti Capital Management first reported a position in AZN in Q2 2013 and has held it in 12 quarters since. The position peaked at $30K in Q4 2013. 1,073 funds tracked by Wall St. Rank hold AZN as of Q3 2023.

Antonetti Capital Management held 100 shares of AstraZeneca worth $13.5K as of Q3 2023.
Antonetti Capital Management left its AstraZeneca share count unchanged in Q3 2023.
AstraZeneca made up 0.02% of Antonetti Capital Management's portfolio in Q3 2023, its #187 holding.
Antonetti Capital Management first reported a position in AstraZeneca in Q2 2013 and has held it in 12 quarters since.
Antonetti Capital Management's AstraZeneca position peaked at $30K in Q4 2013.
1,073 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2023.

Based on Antonetti Capital Management's 13F filing for Q3 2023, filed 9 Nov 2023.